Israel Englander’s Viveon Health Acquisition Corp. VHAQ Stock Holding History

Israel Englander’s Portfolio VHAQ Stock Details VHAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,937	Closed	-$116K	–	7098
2022 Q4	$116K	Sell	10,937 -199,893	-95%	-$2.08M	﹤0.01%	5534
2022 Q3	$2.18M	Sell	210,830 -8,121	-4%	-$83.9K	﹤0.01%	3661
2022 Q2	$2.24M	Buy	218,951 +208,014	+1,902%	+$2.12M	﹤0.01%	3590
2022 Q1	$110K	Sell	10,937 -53,186	-83%	-$535K	﹤0.01%	6101
2021 Q4	$643K	Buy	64,123 +28,876	+82%	+$289K	﹤0.01%	4823
2021 Q3	$352K	Buy	35,247 +19,378	+122%	+$193K	﹤0.01%	5686
2021 Q2	$157K	Buy	+15,869	New	+$157K	﹤0.01%	6107

Other funds holding VHAQ

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Israel Englander's VHAQ Position: Q1 2023 in Review

Israel Englander sold out of Viveon Health Acquisition Corp. (VHAQ) in Q1 2023, closing a stake of 10,937 shares — an estimated $116K sold.

Israel Englander first reported a position in VHAQ in Q2 2021 and held it in 7 quarters. The position peaked at $2.24M in Q2 2022. 5 funds tracked by Wall St. Rank hold VHAQ as of Q1 2023.

Israel Englander reported no remaining Viveon Health Acquisition Corp. position as of Q1 2023 after selling out during the quarter.
Israel Englander sold 10,937 Viveon Health Acquisition Corp. shares in Q1 2023, an estimated $116K.
Israel Englander first reported a position in Viveon Health Acquisition Corp. in Q2 2021 and held it in 7 quarters.
Israel Englander's Viveon Health Acquisition Corp. position peaked at $2.24M in Q2 2022.
5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.